Anti-GD2 Antibody with GM-CSF, Interleukin-2, and Isotretinoin for Neuroblastoma
Alice L. Yu, M.D., Ph.D et al.,
N Engl J Med 2010; 363:1324-1334
Alice L. Yu, M.D., Ph.D et al.,
N Engl J Med 2010; 363:1324-1334
Alice L. Yu, M.D., Ph.D. et al.
N Engl J Med 2010; 363:1324-1334
STUDY CHAIR
Leo Mascarenhas, M.D.
John M. Maris, M.D
N Engl J Med 2010; 362:2202-2211
Cairo, M. S., Coiffier, B. , Reiter, A. , Younes, A. on behalf of the TLS Expert Panel,
British
STUDY CHAIR: A. Lindsay Frazier, M.D., Sc.M.
An open-label study to evaluate the safety and efficacy
of IMATINIB with chemotherapy in pediatric patients with Ph+/BCR-ABL+
The guideline group was selected to be representative of UKbased medical experts.
British Journal of Haematology, 149, 352–375
The writing group produced the draft guideline which was subsequently revised by consensus by members of the Haemostasis
Consensus-based guidelines supported by the literature are presented on the role of prophylactic administration of factor VIII concentrate in children
נותנות החסות לאיגוד:
